Dermalogica reveal new two-phase peel to tackle dark spots
Professional skin brand Dermalogica has launched a new treatment to reduce hyperpigmentation in less than six weeks.
Dermalogica Melanopro Peel System is a two-phase, clinical-strength peel that visibly counteracts environmental skin damage including the appearance of hyperpigmentation such as melasma and sun spots whilst smoothing the skin's texture to reveal a brighter complexion.
Suitable for all skin tones, treatment begins in the salon with an application of Day One Peeling Masque for an intense exfoliation, left on the skin for two to seven hours and removed by the client at home.
This is followed at home with an application of Dermalogica Continuous Resurfacing Cream two to three times a day for up to six weeks. Formulated with 10% azelaic acid, tranexamic acid, glycolic acid, lactic acid, retinol, hexylresorcinol, niacinamide and Acetyl Hexapeptide-1 brightening peptide, this peeling cream stimulates continuous exfoliation.
During the six-week treatment period, skin can be soothed and hydrated by using Dermalogica UltraCalming Mist which eases any redness or sensitivity.
Commenting on the launch of the Melanopro Peel System, Louis Chabert,
Dermalogica's Senior Director of Global Service Innovation, says:
“Until now, the quest for effective and safe hyperpigmentation solutions, particularly for individuals with darker skin tones, has been challenging. Melanopro is a groundbreaking treatment, capable of safely reducing hyperpigmentation across all skin tones in less than six weeks.
“We are proud in providing skin professionals with an exclusive solution for addressing melasma, dark spots, and various hyperpigmentation concerns; and elevate the results they can offer to their patients and clients.”
Available from 1st March, Dermalogica's Melanopro Peel System can be used alone or as part of a professional skin treatment plan combining Laser, IPL, microneedling or dermaplaning.
Dermalogica
